Is abnormal coagulation a possible prognostic factor for efficacy of immunotherapy in metastatic renal cell carcinoma patients?

被引：0
|
作者：
Madzhuga, A. [1 ]
Tsimafeyeu, I. [1 ]
Demidov, L. [1 ]
Somonova, O. [1 ]
Yelizarova, A. [1 ]
机构：
[1] Kidney Canc Res Bur, NN Blokhin Russian Canc Res Ctr, Moscow, Russia
来源：
THROMBOSIS RESEARCH | 2007年 / 120卷
关键词：
D O I：
10.1016/S0049-3848(07)70218-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S165 / S166
页数：2
相关论文
共 50 条
  • [1] Abnormal coagulation as prognostic factor to impact on efficacy of immunotherapy in metastatic renal cell carcinoma patients
    Tsimafeyeu, I.
    Madzhuga, A.
    Demidov, L.
    Somonova, O.
    Yelizarova, A.
    Kharkevich, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 101 - 102
  • [2] Low molecular weight heparin (LMWH) increases the efficacy of immunotherapy in metastatic renal cell carcinoma patients with abnormal coagulation
    Tsimafeyeu, I.
    Madzhuga, A.
    Demidov, L.
    Somonova, O.
    Kharkevich, G.
    Yelizarova, A.
    Petenko, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Immunotherapy with or without low molecular weight heparin in metastatic renal cell carcinoma patients with abnormal coagulation
    Tsimafeyeu, Ilya
    Madzhuga, Albina
    Demidov, Lev
    Somonova, Oksana
    Yelizarova, Anna
    Kharkevich, Galina
    Petenko, Natalia
    ANNALS OF ONCOLOGY, 2007, 18 : 174 - 174
  • [4] Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma
    Kwak, Cheol
    Park, Yong Hyun
    Jeong, Chang Wook
    Jeong, Hyeon
    Lee, Sang Eun
    Moon, Kyung Chul
    Ku, Ja Hyeon
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (04) : 317 - 323
  • [5] Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma
    Kwak, Cheol
    Park, Yong Hyun
    Jeong, Chang Wook
    Jeong, Hyeon
    Lee, Sang Eun
    Ku, Ja Hyeon
    TUMORI JOURNAL, 2007, 93 (01): : 68 - 74
  • [6] Hypercoagulability could be a prognostic factor for response to immunotherapy in patients with metastatic renal cell carcinoma.
    Tsimafeyeu, Ilya
    Madzhuga, Albina
    Demidov, Lev
    CANCER RESEARCH, 2009, 69
  • [7] PROGNOSTIC FACTORS OF METASTATIC RENAL CELL CARCINOMA PATIENTS IN THE IMMUNOTHERAPY ERA
    La Russa, F.
    Riolfi, M.
    Sava, T.
    Ghimenton, C.
    Porcaro, A.
    Cesaro, G.
    Consoli, F.
    Manno, P.
    Pavarana, M.
    Cetto, G. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 197 - 197
  • [8] Prognostic factors of immunotherapy in metastatic renal cell carcinoma
    Padrik, P
    MEDICAL ONCOLOGY, 2003, 20 (04) : 325 - 334
  • [9] Prognostic factors of immunotherapy in metastatic renal cell carcinoma
    Peeter Padrik
    Medical Oncology, 2003, 20 : 325 - 334
  • [10] Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Suppiah, Revathi
    Shaheen, Philip E.
    Elson, Paul
    Misbah, Seema A.
    Wood, Laura
    Motzer, Robert J.
    Negrier, Slyvie
    Andresen, Steven W.
    Bukowski, Ronald M.
    CANCER, 2006, 107 (08) : 1793 - 1800
12345